News

May 31, 2010

Aposense chalks up success in institutional tender
The biotech company raised the NIS 60 million planned in the institutional tender of its IPO.
Avi Shauly and Shiri Habib-Valdhorn

Despite today's stormy session on the Tel Aviv Stock Exchange (TASE), sources inform ''Globes'' that biotechnology company Aposense Ltd. raised the NIS 60 million planned in the institutional tender of its IPO. The amount is 80% of the total amount the company plans to raise.

It remains to be seen what will be the minimum price Aposense will accept in the institutional tender. The company will hold the public tender of the IPO next week.

More News